Episode 617
The CEO of Merck on Race, Leadership, and High Drug Prices
HBR IdeaCast · Harvard Business Review
February 19, 201829m 39s
Audio is streamed directly from the publisher (audio.hbr.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.